CVE-2026-32917
Openclaw command injection
- Published31 Mar 2026
Description
OpenClaw before 2026.3.13 contains a remote command injection vulnerability in the iMessage attachment staging flow that allows attackers to execute arbitrary commands on configured remote hosts. The vulnerability exists because unsanitized remote attachment paths containing shell metacharacters are passed directly to the SCP remote operand without validation, enabling command execution when remote attachment staging is enabled.
CVSS 3.1 breakdown
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HAffected products
Remediation
References
Related CVEs
Recent high-severity vulnerabilities sharing a weakness type.
Frequently asked
Is CVE-2026-32917 being actively exploited?
CVE-2026-32917 is not in the CISA KEV catalog. Its EPSS exploit probability is 3.20%.
How severe is CVE-2026-32917?
CVE-2026-32917 has a CVSS 3.1 base score of 9.8, rated critical. EPSS estimates a 3.20% probability of exploitation.
Which products are affected by CVE-2026-32917?
Affected products include Openclaw.
How do I fix CVE-2026-32917?
Upgrade affected software to a fixed version, for example Openclaw 2026.3.13 or later, then confirm no affected versions remain in your inventory.
How Secuno handles this
Secuno correlates vulnerabilities like CVE-2026-32917 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.
Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.